Dr. Reddy’s receives approval for aspirin and extended-release dipyridamole capsules
Dr. Reddy’s Laboratories announced receipt of approval for aspirin and extended-release dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the U.S. Food and Drug Administration.